Aglaia Biomedical Ventures

Bilthoven, Utrecht, Netherlands ·Founded 2003

Overview

Aglaia identifies groundbreaking opportunities in cancer research and, in close partnerships with inventors and entrepreneurs, takes these opportunities to the next phase of technical and commercial development. Aglaia finds themselves fortunate to be supported by some of the world’s foremost authorities in cancer research and by experienced business people in the biomedical field.

Get the full list of 54,000+ investors

Aglaia Biomedical Ventures and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Aglaia Biomedical Ventures

What sectors does Aglaia Biomedical Ventures invest in?

Aglaia Biomedical Ventures invests in BioTech, and is based in Bilthoven, Utrecht, Netherlands. Aglaia Biomedical Ventures is listed as a investor in the ConnectSafely investor database.

What stage does Aglaia Biomedical Ventures invest at?

Aglaia Biomedical Ventures backs companies at Seed and Series A.

How do I contact Aglaia Biomedical Ventures?

Aglaia Biomedical Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.

Last updated · Source: ConnectSafely investor database